AU511431B2 - 2-substituted-5-alkyl resorcinols - Google Patents

2-substituted-5-alkyl resorcinols

Info

Publication number
AU511431B2
AU511431B2 AU21148/77A AU2114877A AU511431B2 AU 511431 B2 AU511431 B2 AU 511431B2 AU 21148/77 A AU21148/77 A AU 21148/77A AU 2114877 A AU2114877 A AU 2114877A AU 511431 B2 AU511431 B2 AU 511431B2
Authority
AU
Australia
Prior art keywords
substituted
alkyl resorcinols
resorcinols
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU21148/77A
Other languages
English (en)
Other versions
AU2114877A (en
Inventor
H. E. Michaels R. J. Lee C. M. and Plotnikoff N. P Zaugg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU2114877A publication Critical patent/AU2114877A/en
Application granted granted Critical
Publication of AU511431B2 publication Critical patent/AU511431B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • C07C45/66—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups by dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/794—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
    • C07C49/796—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AU21148/77A 1975-11-14 1977-01-07 2-substituted-5-alkyl resorcinols Expired AU511431B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USUS632,126 1975-11-14
US05/632,126 US4018777A (en) 1975-11-14 1975-11-14 2-Substituted-5-alkyl resorcinols

Publications (2)

Publication Number Publication Date
AU2114877A AU2114877A (en) 1978-07-13
AU511431B2 true AU511431B2 (en) 1980-08-21

Family

ID=24534181

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21148/77A Expired AU511431B2 (en) 1975-11-14 1977-01-07 2-substituted-5-alkyl resorcinols

Country Status (18)

Country Link
US (1) US4018777A (OSRAM)
JP (1) JPS5262254A (OSRAM)
AU (1) AU511431B2 (OSRAM)
CA (1) CA1090346A (OSRAM)
CH (1) CH618427A5 (OSRAM)
DE (1) DE2651708A1 (OSRAM)
DK (1) DK506776A (OSRAM)
FI (1) FI763241A7 (OSRAM)
FR (2) FR2361887A1 (OSRAM)
GB (1) GB1541858A (OSRAM)
GR (1) GR61763B (OSRAM)
MX (1) MX4120E (OSRAM)
NL (1) NL7612607A (OSRAM)
NO (1) NO146060C (OSRAM)
PH (1) PH12341A (OSRAM)
PT (1) PT65816B (OSRAM)
SE (1) SE428800B (OSRAM)
ZA (1) ZA766571B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
US20040087590A1 (en) * 2002-08-23 2004-05-06 University Of Connecticut Novel biphenyl and biphenyl-like cannabinoids
WO2004017922A2 (en) * 2002-08-23 2004-03-04 University Of Connecticut Keto cannabinoids with therapeutic indications
ES2663351T3 (es) * 2009-11-17 2018-04-12 Novartis Ag Derivados de aril-piridina como inhibidores de la aldosterona sintasa
MX2019012380A (es) * 2017-05-09 2020-01-23 Eisai R&D Man Co Ltd Cristales de compuesto piranodipiridinico.
CN113874344B (zh) * 2019-03-08 2025-05-27 加利福尼亚大学董事会 8,9-二氢大麻二酚化合物的用途
CA3132861A1 (en) * 2019-03-12 2020-09-17 6th Wave Innovations Corp. Molecularly imprinted polymers for extraction of cannabinoids and uses thereof
CA3199891A1 (en) 2020-11-24 2022-06-02 Ruth Gallily Cannabinoid derivatives and their use for the treatment of inflammation and/or pain and/or obesity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901926A (en) * 1973-04-02 1975-08-26 Abbott Lab Alkylphenyl benzopyrans

Also Published As

Publication number Publication date
NO146060C (no) 1982-08-04
FR2397385B1 (OSRAM) 1980-04-25
JPS5262254A (en) 1977-05-23
NL7612607A (nl) 1977-05-17
SE7612620L (sv) 1977-05-15
ZA766571B (en) 1977-10-26
CH618427A5 (OSRAM) 1980-07-31
NO146060B (no) 1982-04-13
GR61763B (en) 1979-01-09
FI763241A7 (OSRAM) 1977-05-15
PT65816B (en) 1978-05-12
PH12341A (en) 1979-01-16
SE428800B (sv) 1983-07-25
CA1090346A (en) 1980-11-25
FR2361887B1 (OSRAM) 1979-03-09
AU2114877A (en) 1978-07-13
DE2651708A1 (de) 1977-05-18
DK506776A (da) 1977-05-15
NO763881L (OSRAM) 1977-05-18
GB1541858A (en) 1979-03-07
FR2397385A1 (fr) 1979-02-09
PT65816A (en) 1976-12-01
FR2361887A1 (fr) 1978-03-17
MX4120E (es) 1981-12-15
US4018777A (en) 1977-04-19

Similar Documents

Publication Publication Date Title
AU1006976A (en) Inhilator
AU1025376A (en) Pourer-stopper
AU1670276A (en) Tetrahydro-isoquinolines
AU1230276A (en) Amidinoureas
AU1230176A (en) Imidinoureas
AU2018176A (en) Pyrazinecarboxamides
AU1441776A (en) Thieno-pyridines
AU1128976A (en) Magneto-alternator
AU1637076A (en) Banjo-shaped axle-casing
AU1710076A (en) Dihydrooxadiazinones
AU1417076A (en) Propargyl-2 phenylamino-2-impazolines
AU2114877A (en) 2-substituted-5-alkyl resorcinols
AU1867676A (en) N-acetylmuramyl-dorl-alanyl-dorl-isoglutamine
AU1719976A (en) Silacyclo pentenyl-bis-epsilon-caprolactam
AU1565576A (en) L- pyroglutamyl-l-prolinamide
AU503344B2 (en) Substituted sufamylbenzylamines
AU1191776A (en) Fluoro-prostaglandins
AU1408076A (en) Lysolipin Antibioties
AU1520376A (en) Benzocycloheptathiophens
AU1804876A (en) 4-hydroxymethyl-2-pyrrolidinones
AU1393076A (en) Dihydromocimycin
AU1398876A (en) Aryl-di-thioureas
AU4892279A (en) Dentrifrices
AU1612176A (en) Fluoro-steroids
AU505567B2 (en) Substituted benzenedisulfonamide